Nathanael LAROCHETTE

Mr. Nathanael LAROCHETTE

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1999 in Nature
Verified
Journal Article
Closed access
PDF file
SSSantos A. Susin
Santos A. Susin
HLHans-Kristian Lorenzo
Hans-Kristian Lorenzo
NZNaoufal Zamzami
Naoufal Zamzami
IMIsabel Marzo
Isabel Marzo
BSBryan E. Snow
Bryan E. Snow
Guido KroemerGuido Kroemer
Guido Kroemer

24 December 2006 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MOMichel Obeid
Michel Obeid
ATAntoine Tesniere
Antoine Tesniere
Ghiringhelli FrançoisGhiringhelli François
Ghiringhelli François
GFGian Maria Fimia
Gian Maria Fimia
LALionel Apetoh
Lionel Apetoh
Guido KroemerGuido Kroemer
Guido Kroemer

1 February 2005 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
Patricia BoyaPatricia Boya
Patricia Boya
Rosa A. Gonzalez-PoloRosa A. Gonzalez-Polo
Rosa A. Gonzalez-Polo
NCNoelia Casares
Noelia Casares
JPJean-Luc Perfettini
Jean-Luc Perfettini
PDPhilippe Dessen
Philippe Dessen
Guido KroemerGuido Kroemer
Guido Kroemer
Mammalian cells were observed to die under conditions in which nutrients were depleted and, simultaneously, macroautophagy was inhibited either genetically (by a small interfering RNA targeting Atg...

1 April 2000 in The FASEB Journal
Verified
Journal Article
Closed access
EDEric Daugas
Eric Daugas
SSSantos A. Susin
Santos A. Susin
NZNaoufal Zamzami
Naoufal Zamzami
KFKarine F. Ferri
Karine F. Ferri
TITheano Irinopoulou
Theano Irinopoulou
Guido KroemerGuido Kroemer
Guido Kroemer

18 January 1999 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SSSantos A. Susin
Santos A. Susin
HLHans-Kristian Lorenzo
Hans-Kristian Lorenzo
NZNaoufal Zamzami
Naoufal Zamzami
IMIsabel Marzo
Isabel Marzo
CBCatherine Brenner
Catherine Brenner
Guido KroemerGuido Kroemer
Guido Kroemer
The barrier function of mitochondrial membranes is perturbed early during the apoptotic process. Here we show that the mitochondria contain a caspase-like enzymatic activity cleaving the caspase substrate Z-VAD.afc, in addition to three biological activities previously suggested to participate in the apoptotic process: (a) cytochrome c; (b) an apoptosis-inducing factor (AIF) which causes isolated nuclei to undergo apoptosis in vitro; and (c) a DNAse activity. All of these factors, which are biochemically distinct, are released upon opening of the permeability transition (PT) pore in a coordinate, Bcl-2–inhibitable fashion. Caspase inhibitors fully neutralize the Z-VAD.afc–cleaving activity, have a limited effect on the AIF activity, and have no effect at all on the DNase activities. Purification of proteins reacting with the biotinylated caspase substrate Z-VAD, immunodetection, and immunodepletion experiments reveal the presence of procaspase-2 and -9 in mitochondria. Upon induction of PT pore opening, these procaspases are released from purified mitochondria and become activated. Similarly, upon induction of apoptosis, both procaspases redistribute from the mitochondrion to the cytosol and are processed to generate enzymatically active caspases. This redistribution is inhibited by Bcl-2. Recombinant caspase-2 and -9 suffice to provoke full-blown apoptosis upon microinjection into cells. Altogether, these data suggest that caspase-2 and -9 zymogens are essentially localized in mitochondria and that the disruption of the outer mitochondrial membrane occurring early during apoptosis may be critical for their subcellular redistribution and activation.

4 November 2004 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
NVNicola Vahsen
Nicola Vahsen
CCCéline Candé
Céline Candé
JBJean‐Jacques Brière
Jean‐Jacques Brière
PBPaule Bénit
Paule Bénit
NJNicholas Joza
Nicholas Joza
Guido KroemerGuido Kroemer
Guido Kroemer